Chugai Pharma Europe (CPE) has appointed Troy Robinson as Managing Director of its wholly owned commercial subsidiary Chugai Pharma UK (CPU). In his new role, Troy will oversee all UK commercial operations, working alongside colleagues in Germany and France to bolster CPE’s commercial activity across Europe. As part of this, Troy will lead the business in forming new partnerships to bring novel therapies to patients both in the UK, and across the continent.
Troy began his career in financial services, with ten years’ experience in pharmaceuticals and fast-moving consumer goods (FMCG). Since 2012, he has served as a member of the CPU Leadership Team as Finance Director, and later as Head of Corporate Services within CPE. In this role, Troy was critical to maintaining and growing CPE’s consolidated EU turnover and team of 255 highly skilled employees.
